Treace Medical Concepts Inc

Treace Medical Concepts Inc

TMCI

Get informed when a big investor buys or sells

+ Follow
Market Cap$281.55M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Treace Medical Concepts IncTreace Medical Concepts Inc-4.7--88%1.60.2
$-1.41

Current Fair Value

129.3% downside

Overvalued by 129.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$281.55 Million
Enterprise Value$282.03 Million
Dividend Yield$- (-)
Earnings per Share$-0.93
Beta1.4
Outstanding Shares65,049,844

Return

Return on Equity-87.86%ROE
Return on Assets-32.87%
Return on Invested Capital-40.02%

Valuation & Multiples

P/E Ratio-4.67P/E Ratio
PEG53.24PEG
Price to Sales1.61Price to Sales
Price to Book Ratio4.82Price to Book Ratio
Enterprise Value to Revenue1.37
Enterprise Value to EBIT-5.05
Enterprise Value to Net Income-5
Total Debt to Enterprise0.05
Debt to Equity0.19Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 7, 2026
EPS Estimate
$-0.30
Average shareholder expectation
Revenue Estimate
$44.02 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 5, 2026
EPS Estimate
$-0.26
Average shareholder expectation
Revenue Estimate
$47.71 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0000 646.63%
Total Calls- 100.00%
Total Puts- 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %55.71% 0.85%
Total Invested$48.30M 44.99%
Investors Holding117 1.00%

ESG Score

No data

About Treace Medical Concepts Inc

133 employees

Based in Ponte Vedra, FL, Treace Medical Concepts, Inc. is a privately-held medical device company focused on advancing the standard of care for the surgical management of bunion deformities. The Company’s patented Lapiplasty® 3D Bunion ...